Xylem Inc. (XYL) — insider trading
Industrials · NYSE
Xylem Inc. (XYL) has 18 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 1 open-market sale among the most recent 18 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | McShane Geri-Michelle | Officer (SVP, CAO) | Grant / award / vesting | 4,225 | — | $0 | Form 4 |
| 2026-09-01 | van der Berg Andrea Michele | Officer (EVP & Chief Financial Officer) | Grant / award / vesting (derivative) | 6,034 | $106.89 | $645.0K | Form 4 |
| 2026-09-01 | van der Berg Andrea Michele | Officer (EVP & Chief Financial Officer) | Grant / award / vesting | 1,693 | — | $0 | Form 4 |
| 2026-09-01 | Johnston Joseph Patrick | Officer (EVP & President, AW) | Grant / award / vesting (derivative) | 2,298 | $106.89 | $245.6K | Form 4 |
| 2026-09-01 | Johnston Joseph Patrick | Officer (EVP & President, AW) | Grant / award / vesting | 645 | — | $0 | Form 4 |
| 2026-08-13 | KOCH D CHRISTIAN | Director | Grant / award / vesting | 1,247 | $120.27 | $150.0K | Form 4 |
| 2026-05-14 | ELLIS EARL RAY | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | FRIEL ROBERT F | Director | Grant / award / vesting | 2,481 | $116.88 | $290.0K | Form 4 |
| 2026-05-14 | Glatch Lisa | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | Harker Victoria D | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | Morelli Mark D | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | Peribere Jerome A | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | Tretikov Lila | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-14 | Yadav Uday | Director | Grant / award / vesting | 1,711 | $116.88 | $200.0K | Form 4 |
| 2026-05-07 | McShane Geri-Michelle | Officer (SVP, CAO) | Option exercise / conversion (derivative) | 3,147 | — | $0 | Form 4 |
| 2026-05-07 | McShane Geri-Michelle | Officer (SVP, CAO) | Open-market sale | 4,269 | $117.46 | $501.4K | Form 4 |
| 2026-05-07 | McShane Geri-Michelle | Officer (SVP, CAO) | Option exercise / conversion | 3,147 | $86.76 | $273.0K | Form 4 |
| 2026-05-04 | Peribere Jerome A | Director | Open-market purchase | 1,210 | $116.61 | $141.1K | Form 4 |
Ask the chat about XYL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Xylem Inc. (XYL).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.